Skip to Main Content

Paper Details

Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists <b>BAY-4931</b> and <b>BAY-0069</b>.
J Med Chem
5
2022
NCOR1, NCOR2, PPAR, PPARG, benzoxazole, cancer, cell lines, chloro-nitro-arene, muscle-invasive luminal bladder cancer, peroxisome-proliferator-activated receptor-, target genes
Author NameAffiliation
Andrew D CherniackBroad Institute of MIT and Harvard
Andrew D CherniackDana-Farber Cancer Institute
Andrew D CherniackBroad Institute of MIT and Harvard
Andrew D CherniackDana-Farber Cancer Institute
Matthew MeyersonBroad Institute of MIT and Harvard
Matthew MeyersonDana-Farber Cancer Institute
Matthew MeyersonCenter for Cancer Genomics, Dana-Farber Cancer Institute
Matthew MeyersonHarvard Medical School
Matthew MeyersonBroad Institute of MIT and Harvard
Matthew MeyersonDana-Farber Cancer Institute
Matthew MeyersonCenter for Cancer Genomics, Dana-Farber Cancer Institute
Matthew MeyersonHarvard Medical School
  • 1 - 12

Datasets

Release 1.2